research use only

TAS4464 E1 Activating inhibitor

Cat.No.S8849

TAS4464 is a potent and highly selective NEDD8 activating enzyme (NAE) inhibitor with IC50 of 0.955 nM. This compound exhibits superior antitumor activity with prolonged target inhibition.
TAS4464 E1 Activating inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 506.51

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 506.51 Formula

C21H23FN6O6S

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 1848959-10-3 -- Storage of Stock Solutions

Synonyms N/A Smiles CCOC1=CC=CC(=C1C#CC2=C[N](C3OC(CN[S](N)(=O)=O)C(O)C3O)C4=C2C(=NC=N4)N)F

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (197.42 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
NAE [1]
(Cell-free assay)
0.955 nM
In vitro

TAS4464 selectively inhibits NAE relative to the other E1s UAE and SAE. This compound treatment inhibits cullin neddylation and subsequently induces the accumulation of CRL substrates such as CDT1, p27, and phosphorylated IkBa in human cancer cell lines. Cytotoxicity profiling reveals that it is highly potent with widespread antiproliferative activity not only for cancer cell lines, but also patient-derived tumor cells.[1]

In vivo

TAS4464 shows prolonged target inhibition in human tumor xenograft mouse models; weekly or twice a week administration of this compound led to prominent antitumor activity in multiple human tumor xenograft mouse models including both hematologic and solid tumors without marked weight loss.[1]

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02978235 Terminated
Multiple Myeloma|NonHodgkin Lymphoma
Taiho Oncology Inc.
March 1 2017 Phase 1

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map